Would you consider any form of 'maintenance' therapy for a patient in a CR2 following re-challenge with platinum doublet for small cell lung cancer after first line chemo-IO?

There is no data for any kind of maintenance treatment. IO is continued per protocol, but after that I am not aware of any data to support maintenance therapy.

There is no evidence that maintenance chemo would be helpful.